Trademark: 79365471
Word
S-DUAL
Status Date
Monday, May 20, 2024
Filing Date
Tuesday, January 31, 2023
5 Reagents for measurement of HBs antibody; crude medicines; pharmaceutical preparations for activating cellular function; antibodies for veterinary purposes; chemico-pharmaceutical preparations; chemical preparations for use in DNA analysis [medical]; bacterial preparations for medical and veterinary use; chemical preparations for medical or veterinary purposes; biotechnological preparations for medical purposes; biological reagents for medical purposes; biochemical preparations for medical use; reagents for medical use; reagent paper for medical purposes; bispecific antibody for medical purposes; medical diagnostic test strips; trace element preparations for human use; clinical medical reagents; therapeutic drugs and agents; antigens; antibodies
1 Multiple fusion proteins for scientific or research use; diagnostic reagents for scientific or research use; enzymes for scientific or research purposes; bispecific antibody for scientific or medical research use; cell culture reagents for scientific and research use; monoclonal antibodies for scientific purposes; microorganisms for scientific or laboratory purposes; biological preparations for scientific or laboratory purposes; fusion proteins for scientific or laboratory purposes; polymerase for nucleic acid for scientific or laboratory purposes; biochemical preparations for scientific purposes; double antibody reagents for scientific purposes; double antibody reagents in biotechnological product development; biological preparations for use in biotechnology [other than medical]; biochemical catalysts; chemical reagents for use in genetic research
42 Research relating to science; multiple nucleic acid analysis; molecular analysis; development of biotechnology; biochemical analysis; drug discovery services; new product design; pharmaceutical research and development; clinical research in the field of medicine; services for assessing the efficiency of pharmaceuticals; fusion protein analysis; computer programming services in the medical field; medical laboratories; computer project management services relating to imaging medical data; medicine research; analysis and evaluation of medical product development; providing information on the testing, inspection and research of medical products; laboratory services relating to the production of bispecific antibody; drug development of bispecific antibody; research and development for double antibody reagent; evaluating of clinical trial progress; conducting clinical trials
Mar 16, 2023
Sn Assigned For Sect 66a Appl From Ib
Mar 20, 2023
New Application Office Supplied Data Entered
Mar 24, 2023
Application Filing Receipt Mailed
Oct 30, 2023
Assigned To Examiner
Nov 1, 2023
Non-Final Action Written
Nov 2, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Nov 2, 2023
Refusal Processed By Mpu
Nov 2, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Nov 22, 2023
Refusal Processed By Ib
May 16, 2024
Abandonment - Failure To Respond Or Late Response
May 16, 2024
Abandonment Notice Mailed - Failure To Respond
May 16, 2024
Abandonment Notice Mailed - Failure To Respond
May 20, 2024
Teas Response To Office Action Received
May 20, 2024
Teas Petition To Revive Received
May 20, 2024
Petition To Revive-Granted
May 20, 2024
Notice Of Revival - E-Mailed
Aug 14, 2024
Notification Of Possible Opposition Sent To Ib
Aug 14, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Aug 31, 2024
Notification Of Possible Opposition - Processed By Ib
Trademark Alertz updated from USPTO on 2030-01-24
